Genome editing technology deals with engineered nucleases and it is the emerging type of genetic engineering. it is the technology in which the DNA is inserted, deleted or replaced in the genome. The emergence of highly versatile genome-editing technologies has provided investigators with the ability to rapidly and economically introduce sequence-specific modifications into the genomes of a broad spectrum of cell types and organisms. It also promotes various changes in sub cellular level.genome editing itself also holds tremendous potential for treating the underlying various idiopathic genetic causes of certain diseases. The core technologies now most commonly used techniques to facilitate genome editing are clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 9 (Cas9), transcription activator-like effector nucleases (TALENs), zinc-finger nucleases (ZFNs), and homing endonucleases or meganucleases.
Recommended: Gene Therapy Conference | Gene Therapy Event | Gene therapy Meeting | Stem cells Conference | Molecular Biology Conference | Cell Biology Conference
Related Conferences: 2nd World Congress on Stem Cells and Regenerative Medicine, March 14-15, 2019, London, UK | International Conference on Molecular Biology and Stem Cells, November 19-20, 2018, Paris, France | World Congress on Tissue Engineering and Regenerative Medicine, March 14-15, 2019, London, UK | 10th International Conference on Genomics and Molecular Biology May 21-23, 2018, Barcelona, Spain
Related Associations and Societies: Europe: European society of Gene and cell therapy |Foundation for the Accreditation of Cellular Therapy| Alliance for Cancer Gene Therapy | Finnish Society of Gene Therapy| French Society of Cell Therapy and Genetics | Austrian Network for Gene Therapy| British Society of Gene Therapy (BSGT)| Turkish society of Gene and cell therapy| Swedish society of Gene and cell therapy |Spanish society of Gene and cell therapy
USA: American Society of Human Genetics (ASHG) | World Health Organization | American Society of Human Genetics| American Society for Cell Biology | Alliance for cellular signalling | American Society of Gene Therapy| American Association for Cancer Research| American Society of Gene and Cell Therapy
Asia: Australian Gene and Cell Therapy Society| Korean society of Gene and Cell Therapy | Japan society of Gene Therapy | Israeli society of Gene and Cell therapy | The International Centre for and Biotechnology | The Human Genome variation society | Australian Biotechnology Association| Australasian Proteomics Society
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
